These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

360 related articles for article (PubMed ID: 15717861)

  • 1. Maternal plasma VEGF, sVEGF-R1, and PlGF concentrations in preeclamptic and normotensive pregnant Zimbabwean women.
    Muy-Rivera M; Vadachkoria S; Woelk GB; Qiu C; Mahomed K; Williams MA
    Physiol Res; 2005; 54(6):611-22. PubMed ID: 15717861
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Are the maternal and umbilical VEGF-A and SVEGF-R1 altered in pregnancies complicated by preeclampsia with or without intrauterine foetal growth retardation? Preliminary communication.
    Laskowska M; Laskowska K; Leszczyńska-Gorzelak B; Oleszczuk J
    Med Wieku Rozwoj; 2008; 12(1):499-506. PubMed ID: 18663270
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Automated assays for sVEGF R1 and PlGF as an aid in the diagnosis of preterm preeclampsia: a prospective clinical study.
    Sunderji S; Gaziano E; Wothe D; Rogers LC; Sibai B; Karumanchi SA; Hodges-Savola C
    Am J Obstet Gynecol; 2010 Jan; 202(1):40.e1-7. PubMed ID: 19762001
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circulating angiogenic factors and the risk of preeclampsia.
    Levine RJ; Maynard SE; Qian C; Lim KH; England LJ; Yu KF; Schisterman EF; Thadhani R; Sachs BP; Epstein FH; Sibai BM; Sukhatme VP; Karumanchi SA
    N Engl J Med; 2004 Feb; 350(7):672-83. PubMed ID: 14764923
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma carotenoids, retinol, tocopherols, and lipoproteins in preeclamptic and normotensive pregnant Zimbabwean women.
    Williams MA; Woelk GB; King IB; Jenkins L; Mahomed K
    Am J Hypertens; 2003 Aug; 16(8):665-72. PubMed ID: 12878373
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Maternal plasma transforming growth factor-beta1 concentrations in preeclamptic and normotensive pregnant Zimbabwean women.
    Enquobahrie DA; Williams MA; Qiu C; Woelk GB; Mahomed K
    J Matern Fetal Neonatal Med; 2005 May; 17(5):343-8. PubMed ID: 16147848
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence supporting that the excess of the sVEGFR-1 concentration in maternal plasma in preeclampsia has a uterine origin.
    Bujold E; Romero R; Chaiworapongsa T; Kim YM; Kim GJ; Kim MR; Espinoza J; Gonçalves LF; Edwin S; Mazor M
    J Matern Fetal Neonatal Med; 2005 Jul; 18(1):9-16. PubMed ID: 16105786
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Placental growth factor and soluble FMS-like tyrosine kinase-1 in early-onset and late-onset preeclampsia.
    Wikström AK; Larsson A; Eriksson UJ; Nash P; Nordén-Lindeberg S; Olovsson M
    Obstet Gynecol; 2007 Jun; 109(6):1368-74. PubMed ID: 17540809
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dysregulation of circulating autoantibodies against VEGF-A, VEGFR-1 and PlGF in preeclampsia - A role in placental and vascular health?
    Moe K; Heidecke H; Dechend R; Staff AC
    Pregnancy Hypertens; 2017 Oct; 10():83-89. PubMed ID: 29153696
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circulating angiogenic factors in pregnancies complicated by pre-eclampsia.
    Varughese B; Bhatla N; Kumar R; Dwivedi SN; Dhingra R
    Natl Med J India; 2010; 23(2):77-81. PubMed ID: 20925202
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human chorionic gonadotropin, angiogenic factors, and preeclampsia risk: a nested case-control study.
    Asvold BO; Eskild A; Vatten LJ
    Acta Obstet Gynecol Scand; 2014 May; 93(5):454-62. PubMed ID: 24575980
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A prospective cohort study of the value of maternal plasma concentrations of angiogenic and anti-angiogenic factors in early pregnancy and midtrimester in the identification of patients destined to develop preeclampsia.
    Kusanovic JP; Romero R; Chaiworapongsa T; Erez O; Mittal P; Vaisbuch E; Mazaki-Tovi S; Gotsch F; Edwin SS; Gomez R; Yeo L; Conde-Agudelo A; Hassan SS
    J Matern Fetal Neonatal Med; 2009 Nov; 22(11):1021-38. PubMed ID: 19900040
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Placental growth factor (PlGF) is a surrogate marker in preeclamptic hypertension.
    Teixeira PG; Cabral AC; Andrade SP; Reis ZS; da Cruz LP; Pereira JB; Martins BO; Rezende CA
    Hypertens Pregnancy; 2008; 27(1):65-73. PubMed ID: 18293205
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Twin pregnancy and the risk of preeclampsia: bigger placenta or relative ischemia?
    Bdolah Y; Lam C; Rajakumar A; Shivalingappa V; Mutter W; Sachs BP; Lim KH; Bdolah-Abram T; Epstein FH; Karumanchi SA
    Am J Obstet Gynecol; 2008 Apr; 198(4):428.e1-6. PubMed ID: 18191808
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biomarkers of endothelial dysfunction in preeclampsia and neonatal morbidity: a case-control study.
    Masoura S; Kalogiannidis I; Makedou K; Theodoridis T; Koiou K; Gerou S; Athanasiadis A; Agorastos T
    Eur J Obstet Gynecol Reprod Biol; 2014 Apr; 175():119-23. PubMed ID: 24485669
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Altered angiogenesis in preeclampsia: evaluation of a new test system for measuring placental growth factor.
    Schmidt M; Dogan C; Birdir C; Callies R; Kuhn U; Gellhaus A; Janetzko A; Kimmig R; Kasimir-Bauer S
    Clin Chem Lab Med; 2007; 45(11):1504-10. PubMed ID: 17970705
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effective prediction of preeclampsia by a combined ratio of angiogenesis-related factors.
    Lim JH; Kim SY; Park SY; Yang JH; Kim MY; Ryu HM
    Obstet Gynecol; 2008 Jun; 111(6):1403-9. PubMed ID: 18515525
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Maternal serum concentration of placental growth factor (PIGF) and endothelial growth factor (VEGF) in pregnancies complicated by preeclampsia].
    Semczuk-Sikora A; Krzyzanowski A; Kwiatek M; Semczuk M
    Ginekol Pol; 2007 Nov; 78(11):873-6. PubMed ID: 18306920
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circulating angiogenic factors and their association with birth outcomes in preeclampsia.
    Kulkarni AV; Mehendale SS; Yadav HR; Kilari AS; Taralekar VS; Joshi SR
    Hypertens Res; 2010 Jun; 33(6):561-7. PubMed ID: 20224572
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Soluble endoglin and other circulating antiangiogenic factors in preeclampsia.
    Levine RJ; Lam C; Qian C; Yu KF; Maynard SE; Sachs BP; Sibai BM; Epstein FH; Romero R; Thadhani R; Karumanchi SA;
    N Engl J Med; 2006 Sep; 355(10):992-1005. PubMed ID: 16957146
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.